U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C24H26O5
Molecular Weight 394.4602
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PENTOMONE

SMILES

[H][C@@]12CC3=CC=CC(OC)=C3O[C@]1([H])C(C)(C)[C@]4([H])OC5=C(OC)C=CC=C5C[C@]4([H])C2=O

InChI

InChIKey=MTJTVTZUEKVNTG-YJEDKTMASA-N
InChI=1S/C24H26O5/c1-24(2)22-15(11-13-7-5-9-17(26-3)20(13)28-22)19(25)16-12-14-8-6-10-18(27-4)21(14)29-23(16)24/h5-10,15-16,22-23H,11-12H2,1-4H3/t15-,16+,22-,23+

HIDE SMILES / InChI

Molecular Formula C24H26O5
Molecular Weight 394.4602
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Pentomone is a nonsteroidal antiandrogen developed by Lilly Company for postmenopausal patients with metastatic breast cancer who have been previously treated with tamoxifen. It is a prostate growth inhibitor.

Originator

Approval Year

Substance Class Chemical
Record UNII
OPS67T329P
Record Status Validated (UNII)
Record Version